Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - CBRNE - Lung-Damaging Agents, Chloropicrin : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
WORKUP
Treatment
Medication
Follow-up
Miscellaneous
Acknowledgments
Multimedia
References

Related Articles
Acute Respiratory Distress Syndrome

Anaphylaxis

Anxiety

Bronchitis

Burns, Chemical

Burns, Ocular

Burns, Thermal

CBRNE - Chemical Warfare Agents

CBRNE - Incendiary Agents, Magnesium and Thermite

CBRNE - Irritants: Cs, Cn, Cnc, Ca, Cr, Cnb, PS

CBRNE - Lung-Damaging Agents, Chlorine

CBRNE - Lung-Damaging Agents, Chloropicrin

CBRNE - Lung-Damaging Agents, Diphosgene

CBRNE - Lung-Damaging Agents, Phosgene

CBRNE - Lung-Damaging Agents, Toxic Smokes: Nox, Hc, Rp, Fs, Fm, Sgf2, Teflon

CBRNE - Urticants, Phosgene Oxime

Chronic Obstructive Pulmonary Disease and Emphysema

Conjunctivitis

Corneal Abrasion

Corneal Ulceration and Ulcerative Keratitis

Hazmat

Pediatrics, Bronchiolitis

Pediatrics, Croup or Laryngotracheobronchitis

Pediatrics, Epiglottitis

Pediatrics, Foreign Body Ingestion

Pediatrics, Pneumonia

Pediatrics, Reactive Airway Disease

Pediatrics, Respiratory Distress Syndrome

Pneumonia, Aspiration

Pneumonia, Bacterial

Pneumonia, Empyema and Abscess

Pneumonia, Immunocompromised

Pneumonia, Mycoplasma

Pneumonia, Viral

Respiratory Distress Syndrome, Adult

Smoke Inhalation

Sunburn

Toxicity, Chlorine Gas

Toxicity, Phosgene

Ultraviolet Keratitis




Patient Education
Bioterrorism and Warfare Center

Chemical Warfare

Personal Protective Equipment




Author: Kermit D Huebner, MD, FACEP, Research Director, Carl R Darnall Army Medical Center

Kermit D Huebner is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, Association of Military Surgeons of the US, Society for Academic Emergency Medicine, and Society of USAF Flight Surgeons

Coauthor(s): David N Trickey, MD, Staff Physician, Department of Emergency Medicine, Carl R Darnall Army Medical Center

Editors: Mark Keim, MD, Director, Emergency and Disaster Public Health Sciences, Adjunct Assistant Professor, Department of Emergency Medicine, Emory University, National Center for Environmental Health, Centers for Disease Control and Prevention; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Rick Kulkarni, MD, Medical Director, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital; John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center; Robert G Darling, MD, FACEP, Clinical Assistant Professor of Military and Emergency Medicine, Uniformed Services University of the Health Sciences, F Edward Hebert School of Medicine; Director, Center for Disaster and Humanitarian Assistance Medicine

Author and Editor Disclosure

Synonyms and related keywords: nitrochloroform, nitrotrichloromethane, chemical warfare agent, biocidal agent, fungicidal agent, chloropicrin inhalation, chloropicrin exposure, chloropicrin ingestion, contact with chloropicrin, lacrimator, chloropicrin toxicity, lung-damaging agents, lung damaging agents, terrorism



Background

Chloropicrin is a soil fumigant used for its broad biocidal and fungicidal properties, primarily in high-value crops such as strawberries, peppers, onions, tobacco, flowers, tomatoes, and nursery crops. John Stenhouse, a Scottish chemist and inventor, synthesized chloropicrin in 1848. Because chloropicrin is toxic by all routes of entry, it has the potential for widespread destruction as a chemical warfare agent.

Properties, stability, and reactivity

Chloropicrin is a colorless–to–light green oily liquid with an intense and penetrating odor. Even though chloropicrin is not flammable, it is a significant explosion hazard if involved in a fire. Bulk containers of this liquid are shock sensitive and can detonate. Chloropicrin is an irritant to all body surfaces. This liquid decomposes in the environment. Photochemical reactions with chloropicrin produce phosgene; other decomposition products include nitrogen oxides and chlorine compounds. 

Chloropicrin photodegrades, with a half-life of 20 days. It is known to undergo violent reactions with aniline, 3-bromopropyne, sodium hydroxide/alcohol solutions, sodium methoxide, and propargyl bromide. Hazardous polymerization does not occur with chloropicrin.

Detection

The odor is a distinctive warning property of this liquid compound.

Symptoms According to Concentrations

1 ppm*

Irritation with pain in the eyes

4 ppm

Incapacitates exposed individuals

20 ppm

Causes definite bronchial or pulmonary lesions

*Concentrations expressed in parts of material per million parts of air or water.

Pathophysiology

Inhalation

Overexposure leads to irritation of the nose and throat. Chloropicrin is a lacrimator. Exposure to vapors leads to coughing, labored breathing, sore throat, dizziness, bluish skin, vomiting, and in some instances, chemical pneumonitis and pulmonary edema.

Contact with skin or eyes

Contact with chloropicrin can lead to chemical burns or dermatitis manifested by red, cracked, irritated skin. The extent of skin injury depends on the concentration and duration of exposure. Contact with the eyes can cause pain, redness, and tearing. Prolonged eye exposure to chloropicrin can cause blindness. Entrance through damaged skin causes similar symptoms as those seen in overexposure through inhalation.

Ingestion

If ingested, chloropicrin can cause burns to the mouth, throat, and esophagus. Other symptoms are similar to those of overexposure through inhalation. Ingestion of large quantities of chloropicrin liquid can be fatal.

Injection

Overexposure to chloropicrin by injection can lead to redness and irritation of surrounding tissues. Other symptoms are similar to those of overexposure through inhalation.

Chronic exposure

Dermatitis may result from repeated exposure to chloropicrin.

Frequency

United States

Chloropicrin is commonly used as a soil fumigant for agricultural pest control. Human exposures have occurred in the United States, usually in residential areas in close proximity to agricultural areas. The most recently reported large-scale exposure occurred in Kern County, California, in 2003. One hundred sixty-five people developed symptoms as a result of off-site drift of chloropicrin from a nearby agricultural site. Peak concentrations of chloropicrin were estimated to exceed 1 part per million. Nearly all (99%) of those exposed experienced eye pain, burning, or lacrimation. Fifty-one percent experienced respiratory symptoms including cough, dyspnea, or upper respiratory irritation. Nearly half (47%) complained of gastrointestinal complaints such as nausea, vomiting, abdominal pain or diarrhea, and 25% complained of headache.1

Mortality/Morbidity

Fatal chloropicrin exposures have been reported. An intentional ingestion of 100 mL of chloropicrin sodium solution resulted in death from metabolic acidosis and acute heart failure approximately 7 hours after ingestion.2 Homicidal intoxication has also been reported, in which an 18-year-old female died approximately 4 hours after being sprayed with a liquid that was later determined to be chloropicrin. Postmortem examination demonstrated severe pulmonary edema.3

Elevations of creatine phosphokinase levels have been described in the setting of chloropicrin exposure and may represent some degree of rhabdomyolysis.4

Chloropicrin may cause methemoglobinemia.5



History

Clinicians should attempt to elicit an accurate history to involve the setting of exposure. This may occur as an occupational exposure, as an intentional and unintentional industrial release, or as a terrorist attack.

Physical

Physical manifestations depend on the route of exposure.

  • Skin - Evidence of chemical burns or dermatitis manifested by red, cracked, irritated, or bluish skin
  • Eyes - Pain, redness, and tearing
  • Respiratory - Coughing, labored breathing, rales, and rhonchi



Acute Respiratory Distress Syndrome
Anaphylaxis
Anxiety
Bronchitis
Burns, Chemical
Burns, Ocular
Burns, Thermal
CBRNE - Chemical Warfare Agents
CBRNE - Incendiary Agents, Magnesium and Thermite
CBRNE - Irritants: Cs, Cn, Cnc, Ca, Cr, Cnb, PS
CBRNE - Lung-Damaging Agents, Chlorine
CBRNE - Lung-Damaging Agents, Chloropicrin
CBRNE - Lung-Damaging Agents, Diphosgene
CBRNE - Lung-Damaging Agents, Phosgene
CBRNE - Lung-Damaging Agents, Toxic Smokes: Nox, Hc, Rp, Fs, Fm, Sgf2, Teflon
CBRNE - Urticants, Phosgene Oxime
Chronic Obstructive Pulmonary Disease and Emphysema
Conjunctivitis
Corneal Abrasion
Corneal Ulceration and Ulcerative Keratitis
Hazmat
Pediatrics, Bronchiolitis
Pediatrics, Croup or Laryngotracheobronchitis
Pediatrics, Epiglottitis
Pediatrics, Foreign Body Ingestion
Pediatrics, Pneumonia
Pediatrics, Reactive Airway Disease
Pediatrics, Respiratory Distress Syndrome
Pneumonia, Aspiration
Pneumonia, Bacterial
Pneumonia, Empyema and Abscess
Pneumonia, Immunocompromised
Pneumonia, Mycoplasma
Pneumonia, Viral
Respiratory Distress Syndrome, Adult
Smoke Inhalation
Sunburn
Toxicity, Chlorine Gas
Toxicity, Phosgene
Ultraviolet Keratitis


Lab Studies

Laboratory testing should be dictated by clinical presentation and condition of the patient. The provider may consider addition of creatine kinase (CK) and blood gas with co-oximetry. Chloropicrin may be detected by gas chromatography/mass spectrometry (GC/MS). 



Prehospital Care

  • General considerations
    • The rescuer's protective equipment should be Level A (eg, triple gloves [polyethylene gloves and nitrile gloves over latex gloves], fully encapsulating chemical resistant suit and boots, hard hat, self-contained breathing apparatus).
    • Standard organic vapor filters used with gas masks or air-purifying respirators do not remove chloropicrin effectively.
  • Skin exposure
    • Immediately begin decontamination with running water. Flush for a minimum of 15 minutes.
    • Remove contaminated clothing, taking care not to contaminate eyes further.
  • Eye exposure
    • If possible, open victim's eyes while under gentle running water. Use sufficient force to open the eyelids. The victim must "roll" the eyes.
    • Flush for a minimum of 15 minutes.
  • Inhalation
    • Remove the victim to fresh air.
    • Provide assisted ventilation as needed to support pulmonary function.
    • Cover or remove gross contamination to avoid exposure to rescuers.
  • Ingestion
    • Do not induce vomiting.
    • Rinse mouth immediately with water.
    • Have the victim drink milk, egg whites, or large quantities of water if available.

Emergency Department Care

  • Skin exposure: If not completed in the field, continue decontamination with running water for at least 15 minutes.
  • Eye exposure: If not completed in the field, continue flushing for at least 15 minutes.
  • Inhalation
    • Continue assisted ventilation and initiate artificial ventilation as needed to support pulmonary function.
    • In severe respiratory compromise, ventilatory support is mandatory. If a PaO2 cannot be maintained greater than 60 mm Hg with a fraction of inspired oxygen (FIO2) less than or equal to 0.6, then add positive end-expiratory pressure in attempts to open previously closed alveoli.
    • For methemoglobinemia greater than 10-20%, consider administration of methylene blue 1-2 mg/kg as 1% solution intravenously over 5 minutes, followed by a 15-30 mL flush.5
  • Ingestion 
    • Contact poison control for the most current information.
    • Do not induce vomiting.
    • Administer large quantities of water.
    • Do not give diluents to a patient who is convulsing, unconscious, or unable to swallow.



Albuterol and aminophylline may be beneficial in cases involving signs of bronchoconstriction. Use supplemental humidified oxygen in cases of respiratory compromise.

In severe respiratory compromise, ventilatory support is mandatory. If a PaO2 cannot be maintained greater than 60 mm Hg with a fraction of inspired oxygen (FIO2) less than or equal to 0.6, then add positive end-expiratory pressure in attempts to open previously closed alveoli. No specific drug therapy is available for chloropicrin toxicity.

For methemoglobinemia greater than 10-20%, consider the use of methylene blue.5

Drug Category: Sympathomimetic (adrenergic) agents

These agents relieve reversible bronchospasm by relaxing smooth muscles of the bronchi.

Drug NameAlbuterol (Ventolin)
DescriptionStimulates beta-adrenergic receptors. Main effect following oral inhalation is bronchodilation resulting from smooth muscles of bronchial tree. In event of chloropicrin intoxication, use nebulizer route of administration.
Adult DoseDeliver solution nebulized over approximately 5-15 min; doses of 5 mg or even 10 mg nebulized q4-6h may be required in severe toxicity
Pediatric DoseNot recommended
<5 years: Suggested dose 1.25-2.5 mg nebulized; may be administered q4-6h prn with close monitoring for adverse systemic affects
5-12 years: Suggested dosing regimens include nebulized doses of 2.5-5 mg (0.5-1 mL of 0.5% solution)
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsBeta-adrenergic blockers antagonize effects; inhaled ipratropium may increase duration of bronchodilatation by albuterol; cardiovascular effects may increase with MAOIs, inhaled anesthetics, TCAs, and sympathomimetic agents
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsCaution in hyperthyroidism, diabetes mellitus, and cardiovascular disorders

Drug Category: Respiratory smooth muscle relaxant

Aminophylline relieves bronchospasm through smooth muscle relaxation of respiratory tract, thereby increasing flow rates and vital capacity.

Drug NameAminophylline (Aminophyllin)
DescriptionTheophylline compound with ethylenediamine; structurally classified as xanthine derivative. Directly relaxes smooth muscle of respiratory tract.
Adult DoseLoading dose of 6 mg/kg (lean body weight) diluted in 25-50 mL of saline may be given IV over 20 min in event of severe bronchospasm; maintenance infusion of 0.6-0.8 mg/kg may be beneficial
Pediatric Dose<1 year: Not established
1-9 years: Loading dose is 6 mg/kg IV; maintenance infusion is 1-1.2 mg/kg/h
10-16 years: 0.8-1 mg/kg/h IV
>16 years: Administer as in adults
ContraindicationsDocumented hypersensitivity; uncontrolled arrhythmias; peptic ulcers; hyperthyroidism; uncontrolled seizure disorders
InteractionsAminoglutethimide, barbiturates, carbamazepine, ketoconazole, loop diuretics, charcoal, hydantoins, phenobarbital, phenytoin, rifampin, isoniazid, and sympathomimetics may decrease effects of theophylline; theophylline effects may increase with allopurinol, beta-blockers, ciprofloxacin, corticosteroids, disulfiram, quinolones, thyroid hormones, ephedrine, carbamazepine, cimetidine, erythromycin, macrolides, propranolol, and interferon
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsCaution in peptic ulcer, hypertension, tachyarrhythmias, hyperthyroidism, and compromised cardiac function; do not inject IV solution faster than 25 mg/min; patients diagnosed with pulmonary edema or liver dysfunction are at greater risk of toxicity because of reduced drug clearance; monitor theophylline levels on a regular basis

Drug Category: Antidotes

This agent is used to reduce methemoglobin.

Drug NameMethylene blue (Urolene blue)
DescriptionIn reduced form, leukomethylene blue is an electron donor to reduce methemoglobin. Reduction of methylene blue is by NADPH generated by G-6-PD.
Adult Dose1-2 mg/kg IV over 5 min
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; renal insufficiency
InteractionsNone reported
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsIn G-6-PD deficiency, can cause profound anemia; do not inject into CNS



Further Inpatient Care

  • Signs of pulmonary edema may not be evident early after exposure. Observation for 24-48 hours for progression or worsening of symptoms is recommended.5

Patient Education



Medical/Legal Pitfalls

  • Because chloropicrin is toxic by all routes, failure to recognize exposure may result in long-term disability or death.
  • Failure to educate users of chloropicrin in the danger of its use and importance of proper protective equipment can result in unnecessary morbidity or mortality from routine use.

Special Concerns

  • Chloropicrin as a chemical weapon of war
    • Chloropicrin is toxic by all routes of entry, especially by inhalation and ingestion.
    • Short overexposures may cause fatal lung damage.
    • Although not flammable, chloropicrin presents a significant explosion hazard if involved in a fire.
    • Bulk containers are shock sensitive and can detonate.
    • Standard organic vapor filters used with gas masks or air-purifying respirators do not remove chloropicrin effectively.
    • In 1887, while the Germans apparently were considering using lacrimators for military purposes, the French began a chemical warfare program. The French developed a tear gas grenade containing ethyl bromoacetate and proposed artillery shells filled with chloropicrin. In addition, the US War Department's Chemical Warfare Service (CWS) produced chloropicrin-filled artillery shells at the Edgewood Arsenal in Aberdeen, Maryland, as part of the war effort during World War I.



The authors and editors of eMedicine gratefully acknowledge the contributions of previous author, Joanne Williams, MD, to the development and writing of this article.



Media file 1:  Chemical structure of chloropicrin.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Graph

Media file 2:  Level A suit (DuPont Tychem 10,000).
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 3:  Chemical Terrorism Agents and Syndromes. Signs and symptoms. Chart courtesy of North Carolina Statewide Program for Infection Control and Epidemiology (SPICE), copyright University of North Carolina at Chapel Hill, www.unc.edu/depts/spice/chemical.html.
Click to see larger pictureClick to see detailView Full Size Image
 
Media type:  Image



  1. O'Malley MA, Edmiston S, Richmond D, Ibarra M, Barry T, Smith M, et al. Illness associated with drift of chloropicrin soil fumigant into a residential area--Kern County, California, 2003. MMWR Morb Mortal Wkly Rep. Aug 20 2004;53(32):740-2. [Medline][Full Text].
  2. Honda H, Kawashima T, Kaku N, Kawasaki K. [A case of fatal chloropicrine poisoning induced by ingestion]. Chudoku Kenkyu. Oct 2002;15(4):381-4. [Medline].
  3. Gonmori K, Muto H, Yamamoto T, Takahashi K. A case of homicidal intoxication by chloropicrin. Am J Forensic Med Pathol. Jun 1987;8(2):135-8. [Medline].
  4. Prudhomme JC, Bhatia R, Nutik JM, Shusterman DJ. Chest wall pain and possible rhabdomyolysis after chloropicrin exposure. A case series. J Occup Environ Med. Jan 1999;41(1):17-22. [Medline].
  5. Material Safety Data Sheet - Lacrythor Fumigation Warning Agent. Revised October 2006. Material Safety Data Sheet. Available at http://forthor.com/labels/chloropicrin/pic_MSDS.pdf. Accessed January 1, 2008.
  6. Goldman LR, Mengle D, Epstein DM, Fredson D, Kelly K, Jackson RJ. Acute symptoms in persons residing near a field treated with the soil fumigants methyl bromide and chloropicrin. West J Med. Jul 1987;147(1):95-8. [Medline].
  7. Harber LF. The Poisonous Cloud: Chemical Warfare in the First World War. 1986:15-40.
  8. HoltraChem Manufacturing Company, LLC. Material Safety Data Sheet, Chloropicrin. July 30, 1996; revised February 28, 2000.
  9. McEvoy GK, Litvak K, Welsh, Jr. OH. AHFS 96 Drug Information. 1996;861-864, 2654-2657.
  10. Smart JK. History of chemical and biological warfare fact sheets. In: Special Study 50; US Army Chemical and Biologic Defense Command. 1996.
  11. Tintinalli JE. Emergency medicine. JAMA. Jun 19 1996;275(23):1804-5. [Medline].
  12. Wilhelm SN, Sheipier K, Lawrence H. Environmental fate of chloropicrin. In: Fumigants: Environmental Fate, Exposure, and Analysis. 1996.

CBRNE - Lung-Damaging Agents, Chloropicrin excerpt

Article Last Updated: Feb 13, 2008